metronidazole has been researched along with rifamycins in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremmelgaard, A; Jansen, JE | 1 |
| Bernardini, B; Cilli, A; De Simone, C; Delogu, G; Forastieri, EM; Pugnaloni, L; Sorice, F | 1 |
| Barbara, L; Holton, J; Menegatti, M; Vaira, D | 1 |
| Corazza, GR; Di Stefano, M; Mazzocchi, S; Miceli, E; Missanelli, A | 1 |
| Campieri, M; Gionchetti, P; Morselli, C; Rizzello, F; Romagnoli, R | 1 |
| Bronze, MS; Greenfield, R; Greenfield, RA; Salvaggio, M; Sud, B | 1 |
| Shaikh, OS; Sundaram, V | 1 |
| Cima, RR; Holubar, SD; Pardi, DS; Sandborn, WJ | 1 |
| Baban, TA; El-Herte, RI; Kanj, SS | 1 |
| Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, GM; Giorgio, F; Ierardi, E; Inchingolo, CD; Nenna, R; Picchio, M; Tursi, A | 1 |
| Babakhani, F; Bouillaut, L; Gomez, A; Nguyen, L; Sears, P; Sonenshein, AL | 1 |
| Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P | 1 |
| Kale-Pradhan, PB; Palmer, JR; Wilhelm, SM; Zhao, JJ | 1 |
| Guslandi, M | 1 |
| Kamath, PS; Kim, WR; Leise, MD; Poterucha, JJ | 1 |
| Ang, TL; Song, M | 1 |
| Johnson, S; Soriano, MM | 1 |
| Holubar, SD; Pardi, DS; Sandborn, WJ; Singh, S; Stroud, AM | 1 |
| Bridgeman, MB; Dixit, D; Jawaro, T; Yang, A | 1 |
| Bertini, S; Dall'Aglio, M; Dallavalle, L; Menozzi, A; Meucci, V; Quintavalla, F | 1 |
| Albrecht, P; Banasiuk, M; Banaszkiewicz, A; Gawronska, A; Lachowicz, D; Pituch, H | 1 |
12 review(s) available for metronidazole and rifamycins
| Article | Year |
|---|---|
Management of inflammatory bowel disease: does rifaximin offer any promise?
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Absorption; Intestines; Metronidazole; Rifamycins; Rifaximin | 2005 |
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Hepatic encephalopathy: pathophysiology and emerging therapies.
Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc | 2009 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Adult; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction; Rifamycins; Rifaximin; Suppositories | 2010 |
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin | 2012 |
[Hepatic encephalopathy and liver transplantation].
Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2012 |
The role of antimicrobials in Crohn's disease.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Crohn Disease; Humans; Metronidazole; Remission Induction; Rifamycins; Rifaximin; Secondary Prevention; Treatment Outcome | 2013 |
Management of hepatic encephalopathy in the hospital.
Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Metronidazole; Neomycin; Protein Synthesis Inhibitors; Recurrence; Rifamycins; Rifaximin; Terminology as Topic | 2014 |
Second and third line treatment options for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Moxifloxacin; Ofloxacin; Rifabutin; Rifamycins; Rifaximin; Salvage Therapy; Virulence Factors | 2014 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis.
Topics: Adult; Budesonide; Ciprofloxacin; Colitis, Ulcerative; Enema; Gastrointestinal Agents; Humans; Metronidazole; Postoperative Complications; Pouchitis; Randomized Controlled Trials as Topic; Remission Induction; Rifamycins; Rifaximin; Suppositories | 2015 |
Management of Hepatic Encephalopathy: A Primer.
Topics: Anti-Bacterial Agents; Disaccharides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Metronidazole; Neomycin; Practice Guidelines as Topic; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index | 2016 |
2 trial(s) available for metronidazole and rifamycins
| Article | Year |
|---|---|
Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.
Topics: Animals; Anti-Infective Agents; C-Reactive Protein; Chronic Disease; Dog Diseases; Dogs; Female; Inflammatory Bowel Diseases; Male; Metronidazole; Rifamycins; Rifaximin; Treatment Outcome | 2016 |
Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.
Topics: Adolescent; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Immunoenzyme Techniques; Inflammatory Bowel Diseases; Male; Metronidazole; Poland; Prospective Studies; Rifamycins; Rifaximin; Single-Blind Method; Treatment Outcome | 2017 |
8 other study(ies) available for metronidazole and rifamycins
| Article | Year |
|---|---|
Susceptibility testing of 7 antibiotics against anaerobic bacteria: comparison of 2 different media and carbon dioxide concentrations.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbon Dioxide; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Regression Analysis; Rifamycins; Tetracycline | 1987 |
Pharmacokinetic assessment of immunosuppressive activity of antibiotics in human plasma by a modification of the mixed lymphocyte reaction.
Topics: Adult; Aged; Cefotaxime; Chloramphenicol; Female; Gentamicins; Humans; Immunosuppression Therapy; Kinetics; Lymphocytes; Male; Metronidazole; Middle Aged; Rifamycins | 1984 |
The susceptibility of Helicobacter pylori to the rifamycin, rifaximin.
Topics: Ampicillin; Drug Interactions; Drug Therapy, Combination; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Rifamycins; Rifaximin | 1995 |
Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome.
Topics: Anti-Bacterial Agents; Blind Loop Syndrome; Breath Tests; Humans; Hydrogen; Intestinal Absorption; Metronidazole; Rifamycins; Rifaximin | 2005 |
Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis; Colitis, Ulcerative; Colon; Diverticulitis, Colonic; Diverticulosis, Colonic; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Humans; Inflammation; Intestinal Mucosa; Male; Mesalamine; Metronidazole; Middle Aged; Rifamycins; Rifaximin; Syndecan-1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Fidaxomicin inhibits spore production in Clostridium difficile.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Load; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Gene Expression Regulation, Bacterial; Genes, Bacterial; Metronidazole; Microbial Sensitivity Tests; Rifamycins; Rifaximin; Spores, Bacterial; Vancomycin | 2012 |
Rifaximin in the treatment of recurrent Clostridium difficile infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Role of probiotics in the management of pouchitis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Humans; Intestines; Metronidazole; Pouchitis; Probiotics; Proctocolectomy, Restorative; Recurrence; Rifamycins; Rifaximin | 2014 |